News | December 17, 2025
Pfizer cuts 2026 revenue outlook amid COVID-19 & patent losses
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
India plays a critical role in Bristol Myers Squibb’s global strategy
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
Subscribe To Our Newsletter & Stay Updated
